All stocks ยท SHILPAMED
SM

Shilpa Medicare Ltd.

SHILPAMED BSE Drug Manufacturers - Specialty & Generic Healthcare

Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, aโ€ฆ

ISIN INE790G01031
Listed โ€”
Quarters tracked 13
Filings 19 docs

About

Shilpa Medicare Limited offers pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation (CDMO) services in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL. It also provides nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate. In addition, the company offers GLP-1; HpAPI; intermediates; peptides; payloads and linkers; biopolymers; microbial and mammalian products; fermentation; small molecules; monoclonal antibodies and recombinant technology; and tablets, capsules, injectables, oral dissolving films, and transdermal patches. Further, it engages in wind power generation activities. The company serves wholesalers, distributors, doctors, pharmacy chain NGOs, hospitals, government institutions, and companies. The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.

Key Metrics

as of Sep 2026
Market Cap18,863 Cr
P/E66.30
Div Yield0.06 %
Book Valueโ‚น132.00
52w Highโ‚น975.00
52w Lowโ‚น260.00
Face Valueโ‚น1.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 466.00 437.00 410.00 370.00 321.00 331.00 319.00 344.00 293.00 292.00 287.00 313.00 260.00
Expenses 330.00 317.00 296.00 262.00 231.00 252.00 239.00 258.00 222.00 222.00 222.00 255.00 214.00
Operating Profit 136.00 120.00 114.00 108.00 91.00 79.00 81.00 86.00 70.00 70.00 65.00 58.00 46.00
OPM % 29.00 27.00 28.00 29.00 28.00 24.00 25.00 25.00 24.00 24.00 23.00 19.00 18.00
Other Income 9.00 45.00 -13.00 2.00 6.00 -21.00 2.00 5.00 10.00 9.00 2.00 2.00 2.00
Depreciation 35.00 31.00 30.00 30.00 29.00 29.00 29.00 28.00 27.00 27.00 27.00 28.00 27.00
Interest 12.00 14.00 11.00 16.00 19.00 14.00 12.00 26.00 24.00 24.00 26.00 23.00 18.00
Profit before tax 98.00 120.00 61.00 64.00 50.00 15.00 42.00 37.00 29.00 28.00 14.00 9.00 3.00
Tax % -3.00 10.00 27.00 32.00 5.00 5.00 24.00 51.00 51.00 12.00 67.00 83.00 64.00
Net Profit 101.00 108.00 45.00 44.00 47.00 15.00 32.00 18.00 14.00 24.00 5.00 2.00 1.00
EPS in Rs 5.16 5.51 2.28 2.25 2.40 0.74 1.62 0.92 0.72 1.41 0.26 0.09 0.07

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 1,535.001,281.001,146.001,046.001,141.00899.00908.00733.00789.00779.00719.00614.00
Expenses 1,100.00962.00907.00947.00940.00718.00688.00585.00634.00614.00566.00485.00
Operating Profit 435.00319.00239.0099.00202.00181.00219.00148.00155.00165.00153.00129.00
OPM % 28.0025.0021.009.0018.0020.0024.0020.0020.0021.0021.0021.00
Other Income 39.00-8.0015.0017.0021.0090.0017.0033.0022.0015.005.005.00
Interest 59.0076.0092.0059.0041.0022.005.004.003.003.007.004.00
Depreciation 120.00113.00108.0096.0080.0054.0044.0042.0037.0031.0029.0021.00
Profit before tax 295.00122.0054.00-38.00102.00195.00188.00136.00137.00146.00122.00108.00
Tax % 18.0036.0041.00-19.0041.0025.0018.0019.0025.0029.0019.0033.00
Net Profit 243.0078.0032.00-31.0061.00146.00155.00110.00103.00104.0099.0073.00
EPS in Rs 12.444.001.84-1.873.499.069.576.886.456.716.734.78
Dividend Payout % 5.0012.000.000.0016.006.006.007.005.004.004.006.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 20.0010.009.009.009.008.008.008.008.008.008.008.00
Reserves 2,572.002,353.001,800.001,775.001,814.001,471.001,321.001,189.001,077.00979.00639.00539.00
Borrowings 660.00588.00937.00798.00683.00846.00390.00194.00191.00241.00221.00189.00
Other Liabilities 455.00360.00347.00323.00370.00308.00270.00218.00223.00244.00194.00169.00
Total Liabilities 3,706.003,311.003,093.002,904.002,876.002,632.001,989.001,610.001,499.001,472.001,062.00905.00
Fixed Assets 1,593.001,418.001,385.001,368.001,342.001,111.00650.00558.00534.00492.00580.00316.00
CWIP 884.00822.00719.00655.00506.00541.00666.00429.00210.00141.0095.00222.00
Investments 58.0035.0040.0043.0034.0021.0010.002.00140.00253.0053.0066.00
Other Assets 1,170.001,037.00950.00838.00993.00959.00662.00621.00615.00587.00334.00301.00
Total Assets 3,706.003,311.003,093.002,904.002,876.002,632.001,989.001,610.001,499.001,472.001,062.00905.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 342.00132.00137.00180.00105.0047.00124.00147.0045.0037.00129.0069.00
Cash from Investing Activity -339.00-198.00-171.00-232.00-286.00-404.00-290.00-196.00-10.00-257.00-106.00-196.00
Cash from Financing Activity 14.0063.0047.0046.0083.00436.00176.0010.00-61.00313.00-20.00136.00
Net Cash Flow 17.00-3.0013.00-7.00-98.0079.0010.00-39.00-26.0093.003.009.00
Free Cash Flow -28.00-111.00-48.00-46.00-226.00-302.00-220.00-151.00-92.00-79.0012.00-74.00
CFO/OP % 93.0056.0074.00215.0069.0052.0076.00123.0055.0043.00103.0073.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 123.00126.00125.00113.00124.0088.0099.00101.00102.0080.0043.0048.00
Inventory Days 291.00309.00309.00280.00338.00427.00298.00266.00194.00187.00161.00147.00
Days Payable 113.0093.00156.00125.00139.0091.00122.00115.00106.00110.00101.0085.00
Cash Conversion Cycle 301.00342.00278.00268.00323.00425.00275.00253.00189.00157.00104.00111.00
Working Capital Days 51.0080.0048.00-13.0077.0072.0068.0098.0098.0079.0027.0033.00
ROCE % 11.008.005.001.006.008.0012.009.0010.0014.0016.0018.00

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 40.13 40.13 40.13 44.23 44.23 44.23 44.23 44.33 44.39 50.01 50.01 50.01
FIIs 11.39 11.07 10.97 10.92 11.19 10.97 9.90 9.59 9.08 5.63 8.52 8.60
DIIs 8.05 8.58 8.34 7.67 7.46 7.55 8.27 8.18 7.61 1.65 0.06 0.41
Public 40.42 40.21 40.56 37.18 37.10 37.25 37.59 37.90 38.91 42.71 41.41 40.98
No. of Shareholders 60,926 53,410 53,799 52,065 48,636 50,108 49,034 42,784 41,072 46,046 43,630 44,094

Corporate Actions

28 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Bonus 03 Oct 2025 03 Oct 2025 1:1 โ€”
Dividend 17 Sep 2025 17 Sep 2025 โ€” 1.00
Other 06 Sep 2024 โ€” โ€” โ€” Annual General Meeting
Other 22 Sep 2023 โ€” โ€” โ€” Annual General Meeting
Dividend 19 Sep 2022 โ€” โ€” 1.10
Dividend 20 Sep 2021 21 Sep 2021 โ€” 1.10
Other 20 Sep 2021 โ€” โ€” โ€” Annual General Meeting
Dividend 16 Mar 2020 17 Mar 2020 โ€” 1.10
Dividend 12 Sep 2019 โ€” โ€” 1.00
Other 06 Sep 2018 โ€” โ€” โ€” Annual General Meeting
Dividend 01 Mar 2018 05 Mar 2018 โ€” 0.70
Other 21 Sep 2017 โ€” โ€” โ€” Annual General Meeting
Dividend 21 Mar 2017 22 Mar 2017 โ€” 0.60
Other 20 Sep 2016 โ€” โ€” โ€” Annual General Meeting
Dividend 28 Mar 2016 29 Mar 2016 โ€” 0.60
Split 06 Nov 2015 09 Nov 2015 2:1 โ€”
Dividend 16 Sep 2015 โ€” โ€” 1.10
Dividend 11 Sep 2014 โ€” โ€” 1.00
Bonus 16 Jul 2013 โ€” 1:2 โ€”
Dividend 16 Jul 2013 โ€” โ€” 1.30
Dividend 17 Sep 2012 โ€” โ€” 0.90
Dividend 15 Sep 2011 โ€” โ€” 0.80
Dividend 16 Sep 2010 โ€” โ€” 0.70
Dividend 24 Sep 2009 โ€” โ€” 0.50
Dividend 11 Sep 2008 โ€” โ€” 0.40
Other 14 Sep 2004 โ€” โ€” โ€” General
Other 11 Sep 2003 โ€” โ€” โ€” General
Dividend 11 Sep 2002 โ€” โ€” 1.00

Announcements

5 filings